DE69001831D1 - Wirkstoffabgabevorrichtung. - Google Patents

Wirkstoffabgabevorrichtung.

Info

Publication number
DE69001831D1
DE69001831D1 DE9090301617T DE69001831T DE69001831D1 DE 69001831 D1 DE69001831 D1 DE 69001831D1 DE 9090301617 T DE9090301617 T DE 9090301617T DE 69001831 T DE69001831 T DE 69001831T DE 69001831 D1 DE69001831 D1 DE 69001831D1
Authority
DE
Germany
Prior art keywords
delivery device
active substance
substance delivery
piece
female piece
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090301617T
Other languages
English (en)
Other versions
DE69001831T2 (de
Inventor
Marion Eileen Mcneill
Abdul Rashid Abdul Rashid
Howard Norman Ernest Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898903566A external-priority patent/GB8903566D0/en
Priority claimed from GB898921155A external-priority patent/GB8921155D0/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of DE69001831D1 publication Critical patent/DE69001831D1/de
Application granted granted Critical
Publication of DE69001831T2 publication Critical patent/DE69001831T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eye Examination Apparatus (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Surgical Instruments (AREA)
  • Massaging Devices (AREA)
  • Molding Of Porous Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE9090301617T 1989-02-16 1990-02-15 Wirkstoffabgabevorrichtung. Expired - Fee Related DE69001831T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898903566A GB8903566D0 (en) 1989-02-16 1989-02-16 Drug dispensing device
GB898921155A GB8921155D0 (en) 1989-09-19 1989-09-19 Drug dispensing device

Publications (2)

Publication Number Publication Date
DE69001831D1 true DE69001831D1 (de) 1993-07-15
DE69001831T2 DE69001831T2 (de) 1993-09-16

Family

ID=26294964

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090301617T Expired - Fee Related DE69001831T2 (de) 1989-02-16 1990-02-15 Wirkstoffabgabevorrichtung.

Country Status (18)

Country Link
EP (2) EP0384646B1 (de)
JP (1) JPH0818971B2 (de)
KR (1) KR0141473B1 (de)
AT (1) ATE90202T1 (de)
AU (1) AU629915B2 (de)
CA (1) CA2047738C (de)
DE (1) DE69001831T2 (de)
DK (1) DK0384646T3 (de)
ES (1) ES2043270T3 (de)
FI (1) FI913880A0 (de)
GB (1) GB2230442B (de)
HU (1) HU207940B (de)
IE (1) IE64761B1 (de)
NO (1) NO303618B1 (de)
NZ (1) NZ232561A (de)
PT (1) PT93170B (de)
RU (1) RU2104084C1 (de)
WO (1) WO1990009168A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
GB9004702D0 (en) * 1990-03-02 1990-04-25 Polysystems Limited Dispensing device
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
AU652984B2 (en) * 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223146D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Vented capsule
GB9223148D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule cap
SK104895A3 (en) * 1993-02-26 1996-06-05 Procter & Gamble Pharmaceutical composition and its use
DE69332782T2 (de) * 1993-04-20 2003-12-18 Tsrl, Inc. Mehrstufiges arzneistoffabgabesystem
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
GB9323261D0 (en) * 1993-11-11 1994-01-05 Scherer Corp R P Dispensing device
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
PT758244E (pt) 1994-05-06 2002-04-29 Pfizer Formas de dosagem libertacao controlada de azitromicina
GB9718664D0 (en) 1997-09-04 1997-11-05 Scherer Corp R P Improvements in or relating to capsules
GB9724450D0 (en) * 1997-11-20 1998-01-14 Scherer Corp R P Delayed release device
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
AU2546399A (en) 1998-02-10 1999-08-30 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
WO2006009801A2 (en) 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
KR101399911B1 (ko) 2005-03-11 2014-06-19 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 옥트레오타이드의 방출 조절형 제형
ES2560240T5 (es) 2005-07-29 2022-11-08 Stichting Groningen Centre For Drug Res Sistema de suministro pulsátil controlado por pH, métodos para la preparación y uso del mismo
NZ568700A (en) 2005-11-28 2012-03-30 Marinus Pharmaceuticals Solid stabilized particulate formulations comprising ganaxolone
JP2009520824A (ja) 2005-12-20 2009-05-28 セネストラ エルエルシー オメガ３脂肪酸製剤
ES2396039T3 (es) 2006-03-16 2013-02-18 Tris Pharma, Inc. Formulaciones de liberación modificada que contienen complejos de fármaco-resina de intercambio iónico
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
KR101574354B1 (ko) 2007-04-27 2015-12-04 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 이식 장치 이형제 및 이의 사용 방법
US8071537B2 (en) 2008-06-25 2011-12-06 Endo Pharmaceuticals Solutions Inc. Implantable device for the sustained release of a polypeptide
AU2009262263B2 (en) 2008-06-25 2014-08-14 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent
JP5698683B2 (ja) 2009-03-09 2015-04-08 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 治療薬のパルス放出組成物
US20170079962A1 (en) 2009-11-11 2017-03-23 Rapamycin Holdings, Llc Oral Rapamycin Preparation and Use for Stomatitus
US9731025B2 (en) 2010-08-20 2017-08-15 National University Corporation Tokyo Medical And Dental University Pharmaceutical composition for transcolonic absorption
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
DK2688557T3 (da) 2011-03-23 2017-11-27 Ironshore Pharmaceuticals & Dev Inc Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
JP2014521689A (ja) * 2011-08-01 2014-08-28 エイチビー・バイオテクノロジーズ・コーポレーション 流体吸収材料の送達のための難消化性カプセル
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
KR20140108674A (ko) * 2012-01-04 2014-09-12 웰즐리 파마슈티컬스 엘엘씨 배뇨 빈도를 감소시키기 위한 서방형 제제 및 이의 사용 방법
CN104321053A (zh) 2012-03-30 2015-01-28 桑茨利奥&孔帕尼股份有限公司 ω-3脂肪酸酯组合物
BR112015003120B1 (pt) 2012-08-15 2022-08-09 Tris Pharma , Inc Tablete mastigável de liberação estendida de metilfenidato e seu uso
AU2014373683B2 (en) 2013-12-31 2020-05-07 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
EP3302442B1 (de) 2015-06-03 2024-10-16 Triastek, Inc. Darreichungsform und verwendung davon
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CA3023278C (en) * 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
JP7191385B2 (ja) 2017-01-26 2022-12-19 トリアステック インコーポレイテッド 特定の胃腸部位での制御放出の剤形
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills

Also Published As

Publication number Publication date
EP0458887A1 (de) 1991-12-04
CA2047738C (en) 2000-02-15
JPH0818971B2 (ja) 1996-02-28
GB9003503D0 (en) 1990-04-11
KR0141473B1 (en) 1998-06-01
NO303618B1 (no) 1998-08-10
EP0384646A1 (de) 1990-08-29
GB2230442A (en) 1990-10-24
AU5163290A (en) 1990-09-05
CA2047738A1 (en) 1990-08-17
PT93170A (pt) 1990-08-31
RU2104084C1 (ru) 1998-02-10
NZ232561A (en) 1992-02-25
KR920700617A (ko) 1992-08-10
FI913880A0 (fi) 1991-08-16
GB2230442B (en) 1992-11-25
DK0384646T3 (da) 1993-07-12
HU207940B (en) 1993-07-28
PT93170B (pt) 1996-12-31
NO913081D0 (no) 1991-08-08
NO913081L (no) 1991-08-08
ES2043270T3 (es) 1993-12-16
AU629915B2 (en) 1992-10-15
DE69001831T2 (de) 1993-09-16
EP0384646B1 (de) 1993-06-09
WO1990009168A1 (en) 1990-08-23
HU902238D0 (en) 1991-11-28
IE900556L (en) 1990-08-16
IE64761B1 (en) 1995-09-06
HUT58509A (en) 1992-03-30
JPH04505004A (ja) 1992-09-03
ATE90202T1 (de) 1993-06-15

Similar Documents

Publication Publication Date Title
DE69001831D1 (de) Wirkstoffabgabevorrichtung.
ES2006457A4 (es) Un procedimiento para la preparacion de una formulacion farmaceutica.
ES2010648A4 (es) Formulaciones farmaceuticas de sustancias labiles frente a los acidospara uso oral.
ES2049414T3 (es) Dispositivo de administracion.
DE69612481D1 (de) Mit bändern versehene dosisform zur verlängerten freisetzung eines wirkstoffs
JPS649930A (en) Device for drug control release
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
ES2190819T3 (es) Procedimiento de preparacion de formulaciones galenicas noveles que contienen fenobrinato, formulaciones galenicas asi obtenidas y sus aplicaciones.
FR2640547B1 (fr) Materiau composite apte a gonfler en presence d'eau, supports utilisables pour sa fabrication et ses utilisations
SE8803822D0 (sv) Novel dosage form
FI822441A0 (fi) Pao xantinderivat baserade, magen icke irriterande laekemedelsprodukter och foerfarande foer deras framstaellning
ES2053528T5 (es) Composicion farmaceutica que comprende un medicamento y un polimero hinchable en agua.
ATE143805T1 (de) Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
NO306975B1 (no) Orale legemiddelformer og kapselmaterialer for disse
JPS577412A (en) Plaster

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee